Brief: Pharmanutra Sees 2022-2030 CAGR Revenue Growth Of 10.9%

Pharmanutra SpA

21/02/2023 16:52

Feb 21 (Reuters) - Pharmanutra SpA  PHNU.MI :
    * SEES 2022-2030 CAGR REVENUE GROWTH OF 10.9%, WHICH COULD
INCREASE TO UP TO 18.5% DEPENDING ON STRATEGIC GUIDELINES TO
IMPLEMENT

Further company coverage:  PHNU.MI 
 (Reporting by Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48587720920;))